Ultragenyx's Multiple Commercial Assets And Candidates Impress Analyst; Sees...

Published on 15 Jan 2025 on Benzinga · via Yahoo Finance

In conjunction with the 2025 J.P. Morgan Healthcare Conference, the analyst hosted an investor lunch...

Read the rest of the article

Start tracking your investments with Statfolio

Last week, you might have seen that Ultragenyx Pharmaceutical Inc. (NASDAQ:RARE) released its yea...

Simply Wall St. · via Yahoo Finance 15 Feb 2025

We recently published a list of the 12 Biotech Stocks with the Biggest Upside Potential. In this...

Insider Monkey · via Yahoo Finance 17 Jan 2025

In conjunction with the 2025 J.P. Morgan Healthcare Conference, the analyst hosted an investor lu...

Benzinga · via Yahoo Finance 15 Jan 2025

Ultragenyx Pharmaceutical Inc (RARE) reports a 42% year-over-year revenue increase, driven by str...

GuruFocus.com · via Yahoo Finance 6 Nov 2024

Baron Funds, an investment management company, released its “Baron Health Care Fund” third quarte...

Insider Monkey · via Yahoo Finance 1 Nov 2024

We recently compiled a list of the 10 Best Mid-Cap Healthcare Stocks To Buy Now. In this article,...

Insider Monkey · via Yahoo Finance 21 Aug 2024

Key Insights Ultragenyx Pharmaceutical will host its Annual General Meeting on 18th of JuneCEO Em...

Simply Wall St. · via Yahoo Finance 20 Jun 2024

Ultragenyx Pharmaceutical RARE announced positive top-line results from the late-stage study of i...

Zacks via Yahoo Finance 31 May 2024

Total Revenue: Reported $109 million in Q1 2024, an 8% increase year-over-year, falling short of ...

GuruFocus.com via Yahoo Finance 5 May 2024

Ultragenyx Pharmaceutical Inc. (NASDAQ:RARE) just released its latest first-quarter report and th...

Simply Wall St. via Yahoo Finance 4 May 2024